Cellectis SA ALCLS.PA

‎€‎3.280-0.12(-3.53%)(1D)

• Delayed prices by Euronext • in EUR

Invest in Cellectis SA
Today

Create an eToro account to buy ALCLS.PA stock on a secure, user-friendly, multi-asset trading platform.

Cellectis SA ALCLS.PA

Buy ALCLS.PA

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

AP Moeller - Maersk A/S

Reinet Investments SCA

MAX

*Past performance is not an indication of future results

Jump to:

About ALCLS.PA >
How to Buy? >
Top Guides >

The Cellectis SA share price is stable this week.

The Cellectis SA share price today is ‎€‎3.280, reflecting a ‎-3.53‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of ALCLS.PA is ‎€‎245.91M with an average volume in the last three months of 311836.31. The stock has a P/E ratio of -11.38 and a dividend yield of 0%. With the stock’s beta sitting at 0.04

Why invest in stocks on eToro?

Start with ‎$‎50

Low fees

users worldwide

Across 70+ countries

Get Started

ALCLS.PA Key Metrics

Market Cap

‎€‎245.91M

Day’s Range

‎€‎3.24 - ‎€‎3.36

52W Range

‎€‎1.01 - ‎€‎4.822

Average Volume (3M)

311836.31

Price-Earnings Ratio

-11.38

Revenue

‎€‎66.9M

Dividend (Yield)

‎€‎0 (0%)

Prev Close

‎€‎3.4

EPS

‎€‎-0.3

Beta

0.04

How can I buy Cellectis SA stocks?

To purchase Cellectis SA:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Cellectis SA (ALCLS.PA) page and place an order to buy Cellectis SA.

Buy ALCLS.PA

Looking for more information? Check out our guide on Academy.

What Is Cellectis SA?

Cellectis SA is a pioneering biopharmaceutical company specialising in gene-editing technologies. With global operations, the company is dedicated to developing innovative therapies for the treatment of various forms of cancer.

Operating within the healthcare sector, Cellectis SA leverages its advanced gene-editing tools to develop life-saving tools that fight cancer. Its flagship TALEN technology enables the company to develop pioneering immunotherapy products by precisely editing specific genomes.

Keep up to date on the latest share price changes by adding ALCLS.PA stock to your eToro watchlist.

CEO

André Choulika, PhD

Employees

222

Founded

1999

Paris, Ile-de-France, FR

Med Tech

Paris

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Cellectis SA
Today

Create an eToro account to buy ALCLS.PA stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Cellectis SA stock?

The current price of ALCLS.PA is ‎€‎3.280.

What are analysts’ forecasts for Cellectis SA?

Analysts offer forecasts for Cellectis SA based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Cellectis SA?

The market capitalisation of Cellectis SA is ‎€‎245.91M

Daily Movers

Explore the biggest stocks movers on the market.